Tag: ASX:SHL

Sonic Healthcare is finding buying support and we’re likely to see an improvement in the short-term indicators as the stock price stabilizes near the $32.50 level. 

Sonic Healthcare is finding buying support and we’re likely to see an improvement in the short-term indicators as the stock price stabilizes near the $32.50 level. 

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.